NBRV

Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV

Overview Fund Activity
Delisted

NBRV was delisted on the 31st of July, 2023.

Back to rankings

24 hedge funds and large institutions have $187M invested in Nabriva Therapeutics plc Ordinary Shares Ireland in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 4 closing their positions.

Holders
24
Holders Change
-1
Holders Change %
-4%
% of All Funds
0.6%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.1%
New
3
Increased
6
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
O
1
OrbiMed
New York
$41.1M
2
ACP
2
Acuta Capital Partners
California
$9.91M
3
AIP
3
Almanack Investment Partners
Pennsylvania
$1.63M
4
Millennium Management
4
Millennium Management
New York
$764K
5
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$553K

Top Sellers

1
TCM
1
Tekla Capital Management
Massachusetts
$1.68M
2
Deutsche Bank
2
Deutsche Bank
Germany
$417K
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$0
4
OFM
4
Omega Fund Management
Massachusetts
$11.9M
5
FO
5
FT Options
Illinois
$170K
Name Market Value Shares Shares
Change 		Shares
Change %
Acadian Asset Management
26
Acadian Asset Management
Massachusetts
– – -2,041 Closed
TRCT
27
Tower Research Capital (TRC)
New York
– – -503 Closed
NFG
28
Next Financial Group
Texas
– – -122 Closed
1
2